S. Tsousis

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)

John Souglakos, N. Androulakis, K. Syrigos et al. · British Journal of Cancer · 2006 · 403 citations · Full text

Medicine, Oncology, Pharmacology +15

Primary gastric lymphoma – The experience of a General Hospital

Theofanis Economopoulos, C.G. Alexopoulos, N. Stathakis et al. · British Journal of Cancer · 1985 · 42 citations

Medicine, Internal Medicine, Oncology +12

A Phase II Study of Flutamide in Ovarian Cancer

M. Vassilomanolakis, George Koumakis, V. Barbounis et al. · Oncology · 2009 · 27 citations

Medicine, Oncology, Pharmacology +17

Multicenter Phase II Study of Gemcitabine and Oxaliplatin (GEMOX) as Second-Line Chemotherapy in Colorectal Cancer Patients Pretreated with 5-Fluorouracil plus Irinotecan

Nikolaos Ziras, Anna Potamianou, Ioannis Varthalitis et al. · Oncology · 2006 · 18 citations

Medicine, Oncology, Pharmacology +11

A phase II study of ondansetron as antiemetic prophylaxis in patients receiving high-dose polychemotherapy and stem cell transplantation

V. Barbounis, G. Koumakis, M. Vassilomanolakis et al. · Supportive Care in Cancer · 1995 · 14 citations

Pharmacy, Pharmacology, Pharmacotherapy +11